"FDA approves Vertex’s acute pain treatment Journavx" was originally created and published by Pharmaceutical Technology, a ...

A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...

It is important to add pain management to leprosy treatment protocols. This can reduce the challenges that patients face. Read on.

Four in every 10 cancer patients treated with chemotherapy develop severe peripheral nerve pain, a new review suggests.

Cannabidiol (CBD) holds promise as a treatment for many health concerns, including inflammation. For all the known benefits CBD offers, it’s unclear how well it can relieve nerve pain.

Despite high demand for an option like Journavx, doctors fear the drug’s price could be a hangup for insurers and limit ...

Some health problems, including chronic pain, inflammation ... previously responded to this therapy for reasons that are as yet unexplained," says Kaniusas. If nerve stimulation can be customized ...

Worldwide, cancer chemotherapy is linked to persistent severe peripheral nerve pain (neuropathy) for around 4 in every 10 patients treated with these drugs, suggests a pooled data analysis of the ...

The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.

Refractory chronic cough represents a significant unmet need with no FDA-approved treatment options and $11B total addressable global market ...

Nalu Medical announces the FDA clearance for expanded labeling of its Peripheral Nerve Stimulation (PNS) System, now approved ...